Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.28 | 3e-08 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 6e-05 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |